Complementary meds used by 17 percent of elderly with cancer

Complementary meds used by 17 percent of elderly with cancer

(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional status, according to a study published online Feb. 22 in Cancer.

Ronald J. Maggiore, M.D., of the University of Chicago Medical Center, and colleagues evaluated the prevalence of complementary medicine use as well as factors associated with its use among 545 patients (mean age, 73 years) about to start chemotherapy for cancer (61 percent stage IV).

The researchers found that 17 percent of patients reported using at least one complementary medication, with a mean of two medications used per patient. There was an association between complementary medication use and earlier (stage I to II, 29 percent; stage III to IV, 17 percent; odds ratio [OR], 2.05) as well as less impairment in instrumental activities of daily living (OR, 1.39).

"Complementary medication use was reported by 17 percent of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status," the authors write. "Further studies are needed to determine the association between complementary medication use and cancer outcomes among ."

One of the authors disclosed to the pharmaceutical industry.


Explore further

Older patients with colon cancer less likely to receive chemotherapy after surgery

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Citation: Complementary meds used by 17 percent of elderly with cancer (2012, March 2) retrieved 5 July 2020 from https://medicalxpress.com/news/2012-03-complementary-meds-percent-elderly-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments